CRM vs ISRG: Which Is the Better Buy?
Side-by-side comparison of Salesforce, Inc. and Intuitive Surgical, Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-16.
Salesforce, Inc. · Technology
$169.52
+45.0% upside to fair value
Grade A
High Quality
VS
Intuitive Surgical, Inc. · Healthcare
$388.97
+45.0% upside to fair value
Grade B
High Quality
QuantHub Verdict
CRM trades at a lower forward P/E
(19.6x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
CRM |
ISRG |
| Current Price |
$169.52 |
$388.97 |
| Fair Value Estimate |
$245.80 |
$564.01 |
| Upside to Fair Value |
+45.0%
|
+45.0%
|
| Market Cap |
$138.8B |
$137.8B |
| Forward P/E |
19.6x
|
46.5x
|
| EV / EBITDA |
12.3x
|
31.4x
|
| Price / Sales |
3.2x
|
13.0x
|
| Price / FCF |
9.5x
|
48.6x
|
| Revenue Growth YoY |
+13.3%
|
+23.0%
|
| Gross Margin |
77.6%
|
66.3%
|
| Operating Margin |
21.9%
|
30.5%
|
| Return on Equity |
14.9%
|
17.0%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
10.56%
|
2.06%
|
| Analyst Consensus |
Buy
|
Strong Buy
|
Investment Thesis
Salesforce, Inc. is a leading provider of cloud-based software applications primarily focused on customer relationship management (CRM). The company exhibits high business quality with a durable competitive moat supported by strong gross margins of 77.6%, solid operating margin of 21.9%, and a robust return on equity of 14.9%. Recent quarterly revenue growth of 13.3% and earnings growth of 36.7% …
Intuitive Surgical, Inc. operates in the healthcare sector, specializing in medical devices with a strong focus on robotic-assisted surgery systems. The company demonstrates high business quality with a durable competitive moat supported by a 17.0% return on equity, robust gross margin of 66.3%, and solid operating margin of 30.5%. Revenue and earnings growth in the most recent quarter were impre…
Accumulation Zones
| Metric |
CRM |
ISRG |
| Zone Low |
$184.35 |
$423.01 |
| Zone High |
$208.93 |
$479.41 |
| In Buy Zone? |
Yes
|
Yes
|